Firefly Neuroscience, Inc.
AIFF
$2.66
$0.010.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.02% | -1,052.41% | -251.44% | -559.85% | -284.19% |
| Total Depreciation and Amortization | -100.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 539.66% | 18,866.10% | 1,592.65% | 3,096.20% | -21.62% |
| Change in Net Operating Assets | -1,042.72% | -208.59% | 171.94% | -389.68% | 122.99% |
| Cash from Operations | -117.47% | -90.37% | -138.82% | -246.97% | -56.33% |
| Capital Expenditure | 81.25% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 101.04% | -- | -- |
| Cash from Investing | -1,210.50% | 94.66% | 80.31% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -80.84% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 50.79% | -- | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | 60.03% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 984.97% | -12.67% | 173.58% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.36% | 1,631.68% | -53.60% | 59.71% | -620.33% |